Search Results - "Schierle, K."

Report of the working group on the history and ethics of pathology : 105th annual meeting of the German Society of Pathology on in Munster on 10 June 2022 by Braunschweig, T, Schierle, K

Get more information

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study by Jansen-Winkeln, B., Eberth, J., Moulla, Y., Mehdorn, M., Niebisch, S., Schierle, K., Bläker, H., Lordick, F., Gockel, I., Thieme, R.

“…Purpose Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new, palliative approach for patients with peritoneal surface malignancies (PSMs). Its…”
Get full text

Report of the History and Ethics of Pathology Working Group of the German Society for Pathology by Braunschweig, T, Schierle, K

Get more information

Somatostatin receptor subtype expression in human thyroid tumours by Klagge, A, Krause, K, Schierle, K, Steinert, F, Dralle, H, Fuhrer, D

“…Somatostatin receptors (SSTR) are expressed in various endocrine tumours. The expression of SSTR at the tumour cell surface confers the possibility for…”
Get more information

PD-005Response and resistance factor candidates to HER2 targeted therapy in gastric cancer (GC) by Lordick, F, Haffner, I, Luber, B, Maier, D, Kretzschmar, A, Fischer von Weikersthal, L, Riera-Knorrenschild, J, Ahlborn, M, Schierle, K, Wittekind, C

Get full text

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours by Karger, S, Krause, K, Gutknecht, M, Schierle, K, Graf, D, Steinert, F, Dralle, H, Führer, D

“…Background: Previously, we reported a six-marker gene set, which allowed a molecular discrimination of benign and malignant thyroid tumours. Now, we evaluated…”
Get full text

PO-175 Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines by Keller, S, Zwingenberger, G, Ebert, K, Hasenauer, J, Wasmuth, J, Maier, D, Haffner, I, Schierle, K, Weirich, G, Luber, B

“…IntroductionThe molecular mechanism of action of the HER2-targeted antibody trastuzumab is only partially understood, and the direct effects of trastuzumab on…”
Get full text

Report of the working group History and Ethics of Pathology for the 104th annual meeting of the German Society of Pathology in 2020 by Braunschweig, T, Schierle, K

Get full text

Distinct regulation of intrinsic apoptosis in benign and malignant thyroid tumours by Weidinger, C, Karger, S, Krause, K, Schierle, K, Steinert, F, Gimm, O, Dralle, H, Fuhrer, D

“…Aberrations in the control of apoptosis represent a central feature of thyroid carcinogenesis. However, little is known about the regulation of components of…”
Get more information

Meeting of the Working Group on the History and Ethics of Pathology : 103rd Annual Congress of the German Society of Pathology by Braunschweig, T, Schierle, K

Get full text

Scope of activities and research in pathology laboratories from 1920 to 1940 by Braunschweig, T, Schierle, K

“…The ideal of a pathology institute consisted of a large autopsy department and a wide collection of specimens for the training of students and clinically…”
Get full text

Meeting of the Working Group on the History of Pathology : 102nd Annual Congress of the German Society of Pathology by Braunschweig, T, Schierle, K

Get full text

Unilateral Gigantic Exophthalmos in Haemorrhagic Exacerbation of an Orbital Meningioma by Vardarli, M C, Mokán, P, Hupfer, U, Gerressen, M, Hansch, A, Schierle, K, Boicev, A D, Köhler, T K

Get more information

Meeting of the working group on history of pathology on 22nd June 2017 : 101st annual meeting of the German Society of Pathology in Erlangen by Braunschweig, T, Schierle, K

Get full text

Grading of gynecological tumors : Current aspects by Horn, L-C, Mayr, D, Brambs, C E, Einenkel, J, Sändig, I, Schierle, K

“…Histopathological assessment of the tumor grade and cell type is central to the management and prognosis of various gynecological malignancies. Conventional…”
Get full text

Pathologie der Präkanzerosen und der Karzinome von Vulva und Vagina sowie morphologische Prognosefaktoren by Horn, L.-C., Schierle, K.

“…Zusammenfassung Das Vaginal- und das Vulvakarzinom sind mit jeweils ca. 1% aller malignen Tumoren des weiblichen Genitales selten. In Analogie zum…”
Get full text

Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects by Horn, L-C, Brambs, C E, Handzel, R, Mehlhorn, G, Schmidt, D, Schierle, K

“…The majority of precancerous lesions of the lower female genital tract (intraepithelial neoplasia, IN) are caused by human papillomavirus (HPV) infections…”
Get full text

Glomuvenous malformations by Spindler, N, Hanske, S, Schierle, K, Aydogan, E, Böhme, J, Langer, S, Josten, C

“…A patient presented suffering from neural pain in the medial foot for a period of over 20 years. Diagnostic showed a widely spread soft-tissue tumor consisting…”
Get full text

Cervical cancer : Update on morphology by Horn, L-C, Brambs, C E, Handzel, R, Lax, S, Sändig, I, Schmidt, D, Schierle, K

“…The World Health Organization (WHO) classification from 2014 differentiates between different subtypes of mucinous adenocarcinoma of the uterine cervix…”
Get full text

PD-005 Response and resistance factor candidates to HER2 targeted therapy in gastric cancer (GC) by Lordick, F., Haffner, I., Luber, B., Maier, D., Kretzschmar, A., Fischer von Weikersthal, L., Riera-Knorrenschild, J., Ahlborn, M., Schierle, K., Wittekind, C.

Get full text